Tag Archives: AVEO

Top 5 Warren Buffett Stocks To Invest In 2019

General Electric has a mountain of legal problems.

The company’s well-established financial troubles could be made worse by legal headaches that may cost the conglomerate billions of dollars, new filings show.

The SEC is investigating GE’s accounting tactics and its massive insurance losses. The Justice Department is probing GE’s (GE) pre-crisis sale of subprime mortgage. Furious shareholders are suing GE and former top executives over allegedly misleading statements.

JPMorgan estimates that the company faces more than $9.2 billion in damage claims in addition to other potential losses from the SEC and shareholder lawsuits.

Warren Buffett, whose Berkshire Hathaway (BRKA) sold its stake in GE last year, told CNBC on Monday that “clearly there were mistakes made” at GE.

“The accounting at GE has not been a model at all in recent years,” Buffett said.

GE’s stock briefly sank below $14 on Monday for the first time since July 2010.

Top 5 Warren Buffett Stocks To Invest In 2019: Insperity, Inc.(NSP)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Insperity (NSP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Mackay Shields LLC trimmed its holdings in shares of Insperity Inc (NYSE:NSP) by 29.9% in the second quarter, Holdings Channel reports. The firm owned 30,670 shares of the business services provider’s stock after selling 13,100 shares during the period. Mackay Shields LLC’s holdings in Insperity were worth $2,921,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    KBC Group NV lowered its holdings in Insperity Inc (NYSE:NSP) by 92.5% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,064 shares of the business services provider’s stock after selling 13,154 shares during the period. KBC Group NV’s holdings in Insperity were worth $101,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Atlantic Trust Group LLC trimmed its holdings in shares of Insperity Inc (NYSE:NSP) by 16.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 28,152 shares of the business services provider’s stock after selling 5,491 shares during the period. Atlantic Trust Group LLC owned approximately 0.07% of Insperity worth $1,958,000 at the end of the most recent quarter.

  • [By Motley Fool Transcribers]

    Insperity Inc  (NYSE:NSP)Q4 2018 Earnings Conference CallFeb. 11, 2019, 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 5 Warren Buffett Stocks To Invest In 2019: The Rubicon Project, Inc.(RUBI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    The Rubicon Project Inc (NYSE:RUBI) saw unusually-high trading volume on Wednesday . Approximately 1,541,600 shares traded hands during trading, an increase of 150% from the previous session’s volume of 615,518 shares.The stock last traded at $3.22 and had previously closed at $2.90.

  • [By Max Byerly]

    Rubicon Project (NYSE:RUBI) was upgraded by stock analysts at ValuEngine from a “strong sell” rating to a “sell” rating in a research report issued on Wednesday.

  • [By Ethan Ryder]

    Rubicon Project (NYSE: RUBI) is one of 44 publicly-traded companies in the “Computer programming, data processing, & other computer related” industry, but how does it weigh in compared to its competitors? We will compare Rubicon Project to related companies based on the strength of its analyst recommendations, valuation, institutional ownership, dividends, profitability, earnings and risk.

Top 5 Warren Buffett Stocks To Invest In 2019: AVEO Pharmaceuticals, Inc.(AVEO)

Advisors’ Opinion:

  • [By Max Byerly]

    AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) saw unusually-strong trading volume on Tuesday . Approximately 6,349,900 shares were traded during mid-day trading, an increase of 211% from the previous session’s volume of 2,038,523 shares.The stock last traded at $3.15 and had previously closed at $2.83.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on AVEO Pharmaceuticals (AVEO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Lange]

    AVEO Pharmaceuticals Inc. (NASDAQ: AVEO) will be presenting additional data from its Phase 2 data from its tivozanib and nivolumab trial at the European Society of Medical Oncology (ESMO) on October 22. The study is looking to treat advanced renal cell carcinoma.

  • [By Chris Lange]

    AVEO Pharmaceuticals Inc. (NASDAQ: AVEO) will be presenting additional data from its Phase 2 results from its tivozanib and nivolumab trial at the European Society of Medical Oncology (ESMO) on October 22. The study is looking to treat advanced renal cell carcinoma.

Top 5 Warren Buffett Stocks To Invest In 2019: Cathay General Bancorp(CATY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Cathay General Bancorp (NASDAQ:CATY) – Equities research analysts at Piper Jaffray Companies reduced their Q4 2018 EPS estimates for shares of Cathay General Bancorp in a research report issued on Wednesday, July 18th. Piper Jaffray Companies analyst M. Clark now anticipates that the bank will post earnings of $0.76 per share for the quarter, down from their prior estimate of $0.79. Piper Jaffray Companies also issued estimates for Cathay General Bancorp’s Q3 2019 earnings at $0.89 EPS, Q4 2019 earnings at $0.90 EPS, FY2019 earnings at $3.50 EPS, Q1 2020 earnings at $0.89 EPS, Q2 2020 earnings at $0.89 EPS and FY2020 earnings at $3.65 EPS.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Cathay General Bancorp (CATY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Cathay General Bancorp (CATY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Allianz Asset Management GmbH boosted its stake in Cathay General Bancorp (NASDAQ:CATY) by 461.1% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 28,806 shares of the bank’s stock after purchasing an additional 23,672 shares during the quarter. Allianz Asset Management GmbH’s holdings in Cathay General Bancorp were worth $1,152,000 as of its most recent filing with the SEC.

  • [By Stephan Byrd]

    Aurora Investment Counsel bought a new position in shares of Cathay General Bancorp (NASDAQ:CATY) in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 43,515 shares of the bank’s stock, valued at approximately $1,803,000. Aurora Investment Counsel owned 0.05% of Cathay General Bancorp as of its most recent SEC filing.

Top 5 Warren Buffett Stocks To Invest In 2019: Tarena International, Inc.(TEDU)

Advisors’ Opinion:

  • [By Max Byerly]

    Tarena International Inc (NASDAQ:TEDU) has received an average rating of “Hold” from the ten analysts that are currently covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating and seven have given a hold rating to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $16.21.

  • [By Max Byerly]

    K12 (NYSE: LRN) and Tarena International (NASDAQ:TEDU) are both small-cap consumer discretionary companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

  • [By Joseph Griffin]

    Credit Suisse Group cut shares of Tarena International (NASDAQ:TEDU) from an outperform rating to a neutral rating in a report published on Thursday morning, Marketbeat reports.

  • [By Stephan Byrd]

    RYB Education (NYSE: RYB) and Tarena International (NASDAQ:TEDU) are both small-cap consumer discretionary companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, profitability, risk, analyst recommendations, valuation and dividends.

  • [By Joseph Griffin]

    Schroder Investment Management Group trimmed its holdings in Tarena International Inc (NASDAQ:TEDU) by 7.9% in the second quarter, Holdings Channel reports. The fund owned 1,716,054 shares of the business services provider’s stock after selling 146,939 shares during the period. Schroder Investment Management Group’s holdings in Tarena International were worth $12,922,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Tarena International (NASDAQ: TEDU) and Aspen Group (NASDAQ:ASPU) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.

Hot Medical Stocks To Watch For 2019

WellCare (NYSE: WCG) and Trupanion (NASDAQ:TRUP) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, risk, valuation, earnings, institutional ownership, analyst recommendations and profitability.

Valuation and Earnings

Get WellCare alerts:

This table compares WellCare and Trupanion’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
WellCare $17.01 billion 0.58 $373.70 million $8.52 25.83
Trupanion $242.67 million 4.07 -$1.50 million ($0.07) -452.14

WellCare has higher revenue and earnings than Trupanion. Trupanion is trading at a lower price-to-earnings ratio than WellCare, indicating that it is currently the more affordable of the two stocks.

Hot Medical Stocks To Watch For 2019: CenturyLink, Inc.(CTL)

Advisors’ Opinion:

  • [By Billy Duberstein]

    For a great example, look no further than the recent note from MKM analyst Michael Genovese. Genovese anticipates large systems vendor Ciena (NYSE:CIEN) may end up stealing away large customer CenturyLink (NYSE:CTL) from smaller competitor Infinera (NASDAQ:INFN). That could be a huge win for Ciena and a huge blow to Infinera, and the episode is emblematic of this period in the industry.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss in the S&P 500 ahead of the close was CenturyLink, Inc. (NYSE: CTL) which fell about 8% to $21.05. The stock’s 52-week range is $13.16 to $24.20. Volume was about 27.5 million compared to the daily average volume of 9.5 million.

  • [By Leo Sun, Jamal Carnette, CFA, and Nicholas Rossolillo]

    AT&T’s (NYSE:T) massive moat, its high forward yield of 6.2%, and its status as a Dividend Aristocrat make it a favorite income investment for many investors. It might seem tough to find a stable company that pays a higher yield than AT&T, but three stocks fit that description: GEO Group (NYSE:GEO), Brookfield Renewable Energy Partners (NYSE:BEP), and CenturyLink (NYSE:CTL).

  • [By Jason Hall]

    If you bought this time last year, Centurylink Inc. (NYSE:CTL) and Pattern Energy Group Inc. (NASDAQ:PEGI) haven’t exactly been great investments, with share prices down 33% and 19%, respectively, while the S&P 500 (SNPINDEX:^GSPC) has gained 15%. Even when we factor in dividends, they lost investors money while the market delivered more than 17% in total returns. 

  • [By Rick Munarriz]

    The quest for chunky dividends has sent income investors scurrying into independent local exchange carriers in the past, but it’s a whole new ballgame in the telecom space these days. Frontier Communications (NASDAQ:FTR) — which at one point earlier this year was packing a yield north of 36% — suspended its payout in February. CenturyLink (NYSE:CTL) is still shelling out a fat dividend that yields nearly 12%, but it has been making needle-moving acquisitions to diversify its business. 

Hot Medical Stocks To Watch For 2019: Annaly Capital Management Inc(NLY)

Advisors’ Opinion:

  • [By Paul Ausick]

    Annaly Capital Management Inc. (NYSE: NLY) traded down about 0.8% Friday to set a new 52-week low of $9.81 after closing at $9.89 on Thursday. The stock’s 52-week high is $12.40. Volume was about 15% lower than the daily average of around 12.3 million. The company had no specific news.

  • [By Sean Williams]

    Second, and building on that previous point, what mortgage REITs might lack with a less-than-perfect rising-rate environment, they’ve gained in managerial experience. With the exception of industry juggernaut Annaly Capital Management (NYSE:NLY), virtually no other mortgage REITs had much experience prior to the Great Recession. However, most of these publicly traded mortgage REITs now have a decade or more of experience under their belts. This experience should come in handy as lending rates rise.

  • [By Max Byerly]

    Shares of ANNALY Cap Mgmt/SH (NYSE:NLY) have received a consensus recommendation of “Hold” from the eight brokerages that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the company. The average 1-year price target among analysts that have covered the stock in the last year is $10.88.

  • [By Brian Feroldi, Matthew Frankel, and Dan Caplinger]

    So, which dividend stocks do we Fools like right now? We asked a team of investing experts to weigh in, and they picked Annaly Capital Management (NYSE:NLY), Digital Realty (NYSE:DLR), and Brookfield Infrastructure Partners (NYSE:BIP). 

Hot Medical Stocks To Watch For 2019: AVEO Pharmaceuticals, Inc.(AVEO)

Advisors’ Opinion:

  • [By George Budwell]

    Shares of AVEO Pharmaceuticals (NASDAQ:AVEO) gained a healthy 10.7% last month, according to data from S&P Global Market Intelligence. The spark?

  • [By Maxx Chatsko]

    Shares of AVEO Pharmaceuticals (NASDAQ:AVEO) fell 17% today after the company announced first-quarter 2018 results and provided a business update. As a development stage biopharma company, there’s wasn’t much in the way of new financial details. However, the company did announce that it was delaying the expected readout of top-line data from the ongoing phase 3 trial of its lead drug candidate from the second quarter of 2018 to the third quarter of 2018.

  • [By Joseph Griffin]

    Here are some of the news articles that may have impacted Accern’s analysis:

    Get AVEO Pharmaceuticals alerts:

    AVEO Pharmaceuticals, Inc. (AVEO) Expected to Announce Quarterly Sales of $670,000.00 (americanbankingnews.com) Notable Stocks on the Move – AVEO Pharmaceuticals, Inc., (NASDAQ: AVEO) (nysenewstoday.com) AVEO Pharmaceuticals, Inc. (AVEO)- Profitability Ratios under Review (topdesertsafari.com) Buy And Hold, And Diversify: AVEO Pharmaceuticals, Inc. (AVEO), American International Group, Inc. (AIG) (nmsunews.com) Switching Stocks: AVEO Pharmaceuticals, Inc., (NASDAQ: AVEO), Graphic Packaging Holding Company, (NYSE: GPK) (nysetradingnews.com)

    NASDAQ AVEO traded up $0.10 on Tuesday, hitting $2.37. 1,781,596 shares of the company traded hands, compared to its average volume of 2,022,071. The company has a market capitalization of $277.34 million, a PE ratio of -14.81 and a beta of 1.55. The company has a debt-to-equity ratio of -0.36, a quick ratio of 1.16 and a current ratio of 1.16. AVEO Pharmaceuticals has a 52-week low of $1.86 and a 52-week high of $4.24.

  • [By Chris Lange]

    AVEO Pharmaceuticals Inc. (NASDAQ: AVEO) will be presenting additional data from its Phase 2 data from its tivozanib and nivolumab trial at the European Society of Medical Oncology (ESMO) on October 22. The study is looking to treat advanced renal cell carcinoma.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on AVEO Pharmaceuticals (AVEO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Medical Stocks To Watch For 2019: Sinovac Biotech Ltd.(SVA)

Advisors’ Opinion:

  • [By Joseph Griffin]

    News articles about Sinovac Biotech (NASDAQ:SVA) have been trending somewhat positive this week, Accern reports. The research firm identifies negative and positive news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Sinovac Biotech earned a coverage optimism score of 0.12 on Accern’s scale. Accern also assigned media stories about the biopharmaceutical company an impact score of 45.8977999719642 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Hot Medical Stocks To Watch For 2019: United States Steel Corporation(X)

Advisors’ Opinion:

  • [By Lee Jackson]

    This venerable steel producer remains a favorite on Wall Street. United States Steel Corp. (NYSE: X) produces and sells flat-rolled and tubular steel products in North America and Europe. It operates through three segments. Its Flat-Rolled Products segment offers slabs, rounds, strip mill plates, sheets and tin mill products. This segment serves customers in the automotive, consumer and the combined industrial, service center and mining commercial markets.

  • [By Neha Chamaria]

    Shares of United States Steel (NYSE:X) plunged 18.5% in August, according to data from S&P Global Market Intelligence. The steelmaker announced its second-quarter earnings on the first day of the month, but there’s more to the stock’s drop than just the numbers. 

  • [By Dan Caplinger]

    Monday was a big day on Wall Street, with major benchmarks moving generally higher to start the week. Strong performance in the energy market once again led stocks higher, including a nice gain in oil prices to move above the $72-per-barrel mark. The small-cap Russell 2000 Index hit another record high, but some companies reported news that prevented them from participating in the broader-based rally. Fifth Third Bancorp (NASDAQ:FITB), Qudian (NYSE:QD), and U.S. Steel (NYSE:X) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Matthew DiLallo]

    Shares of U.S. Steel (NYSE:X) have been red-hot over the past year, surging nearly 60%. Driving those gains has been a significant improvement in the company’s earnings due to higher steel prices. In the first quarter, the steelmaker reported $57 million, or $0.32 per share, of adjusted earnings, which was a vast improvement from the adjusted loss of $145 million, or $0.83 per share, it reported in the year-ago quarter.

Hot Medical Stocks To Watch For 2019: Plains Group Holdings, L.P.(PAGP)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Plains GP (NYSE:PAGP) was upgraded by analysts at US Capital Advisors from a hold rating to an overweight rating.

    Rewalk Robotics (NASDAQ:RWLK) was given a $2.00 price target by analysts at Oppenheimer Holdings Inc.. The firm currently has a buy rating on the stock.

  • [By Shane Hupp]

    News coverage about Plains GP (NYSE:PAGP) has been trending somewhat positive on Sunday, according to Accern Sentiment Analysis. The research firm scores the sentiment of press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Plains GP earned a news impact score of 0.18 on Accern’s scale. Accern also assigned news coverage about the pipeline company an impact score of 46.0549967457103 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

  • [By Joseph Griffin]

    Here are some of the news articles that may have impacted Accern’s rankings:

    Get Plains GP alerts:

    Plains GP (PAGP) Posts Quarterly Earnings Results, Misses Expectations By $0.08 EPS (americanbankingnews.com) Plains GP (PAGP) Upgraded by TheStreet to C- (americanbankingnews.com) Plains GP (PAGP) Downgraded by Stifel Nicolaus (americanbankingnews.com) Plains GP Holdings (PAGP) Tops Q1 EPS by 5c, Beats on Revenues (streetinsider.com) Plains All American Pipeline, L.P. and Plains GP Holdings Report First-Quarter 2018 Results (finance.yahoo.com)

    Several research firms have commented on PAGP. TheStreet upgraded shares of Plains GP from a “d+” rating to a “c-” rating in a research report on Monday. Stifel Nicolaus cut shares of Plains GP from a “buy” rating to a “hold” rating and set a $24.00 target price for the company. in a research report on Wednesday. Jefferies Group cut shares of Plains GP from a “buy” rating to a “hold” rating in a research report on Wednesday, April 25th. Wolfe Research cut shares of Plains GP from a “market perform” rating to an “underperform” rating in a research report on Tuesday, April 24th. Finally, Deutsche Bank began coverage on shares of Plains GP in a research report on Thursday, April 19th. They issued a “buy” rating and a $29.00 target price for the company. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $25.65.

  • [By Stephan Byrd]

    Plains GP (NYSE:PAGP) last announced its quarterly earnings data on Tuesday, February 5th. The pipeline company reported $1.12 EPS for the quarter, beating the Zacks’ consensus estimate of $0.51 by $0.61. Plains GP had a net margin of 0.98% and a return on equity of 2.69%. The firm had revenue of $8.79 billion during the quarter, compared to the consensus estimate of $10.52 billion. During the same quarter last year, the firm earned ($5.16) earnings per share. The firm’s revenue was up 15.5% compared to the same quarter last year. Analysts expect that Plains GP Holdings LP will post 1.61 EPS for the current year.

good penny stocks

Watch out, big banks. Silicon Valley is targeting finance as the next industry ripe for disruption.

In the not-too-distant-future, Amazon (AMZN) could let customers zap each other cash with Alexa, and then deposit the money in an Amazon-branded checking account.

Apple (AAPL) is reportedly on the verge of launching a joint credit card with Goldman Sachs (GS) that would carry the Apple Pay brand. And Facebook (FB) just formed a team to explore the power of blockchain that could include creating its own cryptocurrency for payments.

Big Tech’s experiment with finance is aimed at deepening relationships with customers — especially younger ones — making it less likely they’ll go through the hassle of taking their business elsewhere.

“There has been a clear shift, with much more aggression into the banking space,” said Daniel Ives, chief strategy officer at research firm GBH Insights.

“Technology companies are trying to get further entrenched in the consumer lifestyle,” he said.

good penny stocks: AVEO Pharmaceuticals, Inc.(AVEO)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Shares of AVEO Pharmaceuticals (NASDAQ:AVEO) fell 17% today after the company announced first-quarter 2018 results and provided a business update. As a development stage biopharma company, there’s wasn’t much in the way of new financial details. However, the company did announce that it was delaying the expected readout of top-line data from the ongoing phase 3 trial of its lead drug candidate from the second quarter of 2018 to the third quarter of 2018.

good penny stocks: Wipro Limited(WIT)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    United Technologies Corporation (NYSE: UTX) is estimated to report quarterly earnings at $1.51 per share on revenue of $14.62 billion.
    The Coca-Cola Company (NYSE: KO) is expected to report quarterly earnings at $0.46 per share on revenue of $7.31 billion.
    Caterpillar Inc. (NYSE: CAT) is projected to report quarterly earnings at $2.07 per share on revenue of $11.93 billion.
    Verizon Communications Inc. (NYSE: VZ) is expected to report quarterly earnings at $1.11 per share on revenue of $31.22 billion.
    Lockheed Martin Corporation (NYSE: LMT) is estimated to report quarterly earnings at $3.42 per share on revenue of $11.28 billion.
    The Sherwin-Williams Company (NYSE: SHW) is projected to report quarterly earnings at $3.15 per share on revenue of $3.94 billion.
    Biogen Inc. (NASDAQ: BIIB) is expected to report quarterly earnings at $5.92 per share on revenue of $3.15 billion.
    3M Company (NYSE: MMM) is estimated to report quarterly earnings at $2.52 per share on revenue of $8.26 billion.
    JetBlue Airways Corporation (NASDAQ: JBLU) is projected to report quarterly earnings at $0.2 per share on revenue of $1.75 billion.
    Eli Lilly and Company (NYSE: LLY) is expected to report quarterly earnings at $1.13 per share on revenue of $5.49 billion.
    Harley-Davidson, Inc. (NYSE: HOG) is estimated to report quarterly earnings at $0.88 per share on revenue of $1.25 billion.
    Corning Incorporated (NYSE: GLW) is expected to report quarterly earnings at $0.3 per share on revenue of $2.50 billion.
    Centene Corporation (NYSE: CNC) is projected to report quarterly earnings at $1.88 per share on revenue of $13.28 billion.
    The Travelers Companies, Inc. (NYSE: TRV) is estimated to report quarterly earnings at $2.77 per share on revenue of $6.75 billion.
    Wipro Limited (NYSE: WIT) is expected to report quarterly earnings at $0.07 per share on revenue of $2.16 billion.
    PACCAR Inc (NASDAQ: PCAR) is projected to
  • [By Lisa Levin] Companies Reporting Before The Bell
    Thermo Fisher Scientific Inc. (NYSE: TMO) is projected to report quarterly earnings at $2.4 per share on revenue of $5.63 billion.
    Ford Motor Company (NYSE: F) is expected to report quarterly earnings at $0.41 per share on revenue of $37.16 billion.
    Twitter, Inc. (NYSE: TWTR) is projected to report quarterly earnings at $0.11 per share on revenue of $605.26 million.
    Comcast Corporation (NASDAQ: CMCSA) is expected to report quarterly earnings at $0.59 per share on revenue of $22.75 billion.
    General Dynamics Corporation (NYSE: GD) is estimated to report quarterly earnings at $2.52 per share on revenue of $7.6 billion.
    The Boeing Company (NYSE: BA) is expected to report quarterly earnings at $2.58 per share on revenue of $22.24 billion.
    Anthem, Inc. (NYSE: ANTM) is estimated to report quarterly earnings at $4.91 per share on revenue of $22.52 billion.
    Viacom, Inc. (NASDAQ: VIAB) is projected to report quarterly earnings at $0.79 per share on revenue of $3.04 billion.
    Northrop Grumman Corporation (NYSE: NOC) is estimated to report quarterly earnings at $3.61 per share on revenue of $6.61 billion.
    Rockwell Automation Inc. (NYSE: ROK) is expected to report quarterly earnings at $1.81 per share on revenue of $1.66 billion.
    Wipro Limited (NYSE: WIT) is projected to report quarterly earnings at $0.07 per share on revenue of $2.15 billion.
    The Goodyear Tire & Rubber Company (NASDAQ: GT) is expected to report quarterly earnings at $0.46 per share on revenue of $3.82 billion.
    Owens Corning (NYSE: OC) is projected to report quarterly earnings at $0.97 per share on revenue of $1.62 billion.
    T. Rowe Price Group, Inc. (NASDAQ: TROW) is estimated to report quarterly earnings at $1.71 per share on revenue of $1.29 billion.
    Dr Pepper Snapple Group, Inc. (NYSE: DPS) is expected to report quarterly earnings at $1.04 per share on revenue of $1.57 billion.
    Sirius XM Holdings Inc. (NASDAQ: SI

good penny stocks: Orocobre Limited (OROCF)

Advisors’ Opinion:

  • [By ]

    Early-stage lithium producer Orocobre (OTCPK:OROCF) has been busy developing its Argentine flag-ship asset at Olaroz. The company has managed to scale up the asset to around 12,000 T / year LCE with a nameplate production capacity of 17,500 T / year. Although the company has not achieved full production capacity at its asset, it has moved ahead with joint venture partner Toyota Tsusho (OTCPK:TYHOF) to develop plans for Phase 2. In January 2018, Orocobre announced that Toyota Tsusho would invest nearly $300 million for a 15% stake in the company, along with plans to double production capacity at Olaroz to 42,000 T LCE / year. The joint venture is also building a lithium hydroxide facility in Japan which will supply the local battery supply chain.

good penny stocks: Arc Wireless Solutions Inc.(ARCW)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Watts Water Technologies (NYSE: WTS) and ARC Group WorldWide (NASDAQ:ARCW) are both computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations.

good penny stocks: Panasonic Corporation (PCRFY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    JOLED is a company that was established in 2014 by by Japan Display, Sony (NYSE:SNE) and Panasonic (OTCPK:PCRFY). And they are not the only ones:

    During an OLED display Seminar in Korea, UniJet’s CEO Kim Seok-Soon said that new advances in Ink-Jet printing technologies could enable displays that are over 500 PPI – and so make printing a viable technology to produce small and medium-sized OLED panels.

  • [By ]

    CBAK is in a very competitive industry, as well as being small relative to its competitors. Among the Company’s competitors are giants like Panasonic (OTCPK:PCRFY) and Samsung (OTC:SSNLF), but overall it faces competition from Japan, Korea, and China. Although CBAK states that “we are able to leverage our low-cost advantage to compete favorably with our competitors”, it is hard to see that being the reality, especially when looking at the above gross margins. Still, the Company may enjoy lower labor costs, since it sources labor locally and apparently it has “higher consistency and safety in product quality, which enables us to compete favorably with local competitors”. But given the greater resources of at least some of its competitors and the constantly evolving dynamics of the industry, competition is surely a risk factor to consider.

good penny stocks: Dicerna Pharmaceuticals, Inc.(DRNA)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Dicerna Pharmaceuticals (NASDAQ:DRNA) was upgraded by stock analysts at BidaskClub from a “hold” rating to a “buy” rating in a report released on Friday.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Agilent Technologies, Inc. (NYSE: A) is estimated to post quarterly earnings at $0.64 per share on revenue of $1.21 billion.
    Vipshop Holdings Limited (NYSE: VIPS) is expected to post quarterly earnings at $0.18 per share on revenue of $3.10 billion.
    Rexnord Corporation (NYSE: RXN) is projected to post quarterly earnings at $0.39 per share on revenue of $551.94 million.
    Invitation Homes Inc. (NYSE: INVH) is estimated to post quarterly earnings at $0.03 per share on revenue of $423.13 million.
    Switch, Inc. (NYSE: SWCH) is expected to post quarterly earnings at $0.05 per share on revenue of $99.83 million.
    Itron, Inc. (NASDAQ: ITRI) is projected to post quarterly earnings at $0.13 per share on revenue of $579.85 million.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) is expected to post quarterly earnings at $0.44 per share on revenue of $119.06 million.
    Amyris, Inc. (NASDAQ: AMRS) is estimated to post quarterly earnings at $0.07 per share on revenue of $68.14 million.
    Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA) is projected to post quarterly loss at $0.38 per share on revenue of $1.87 million.
    VOXX International Corporation (NASDAQ: VOXX) is expected to post quarterly earnings at $0.05 per share on revenue of $130.00 million.
    Phoenix New Media Limited (NYSE: FENG) is estimated to post quarterly loss at $0.12 per share on revenue of $45.38 million.
    Restoration Robotics, Inc. (NASDAQ: HAIR) is projected to post quarterly loss at $0.17 per share on revenue of $5.93 million.
    YogaWorks, Inc. (NASDAQ: YOGA) is estimated to post quarterly loss at $0.22 per share on revenue of